Paul Rocchi
Light Matter Institute, UMR-5306
Villeurbanne, 69622, France
Villeurbanne, 69622, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors.
Journal: Nanoscale
Published: December 19, 2023
Tuning ultrasmall theranostic nanoparticles for MRI contrast and radiation dose amplification.
Journal: Theranostics
Published: April 27, 2023
Added Value of Scintillating Element in Cerenkov-Induced Photodynamic Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 12, 2022
A New Generation of Ultrasmall Nanoparticles Inducing Sensitization to Irradiation and Copper Depletion to Overcome Radioresistant and Invasive Cancers.
Journal: Pharmaceutics
Published: February 24, 2022
Identification of Molecular Fragments in Equilibrium with Polysiloxane Ultrasmall Nanoparticles.
Journal: Nanomaterials (Basel, Switzerland)
Published: February 02, 2022
Biodegradation of metal-based ultra-small nanoparticles: A combined approach using TDA-ICP-MS and CE-ICP-MS.
Journal: Analytica chimica acta
Published: June 11, 2021
Terbium-Based AGuIX-Design Nanoparticle to Mediate X-ray-Induced Photodynamic Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 24, 2021
Unique features of brain metastases-targeted AGuIX nanoparticles vs their constituents: A focus on glutamate-/GABA-ergic neurotransmission in cortex nerve terminals.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: October 15, 2020
Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma.
Journal: International journal of nanomedicine
Published: May 12, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026